Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268

Clinical trial NCT06507839 · COMPLETED

Trial details

NCT number: NCT06507839
Sponsor: Thryv Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2024-05-15
Primary completion: 2024-11-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.